Characterizing the contribution of hippo pathway dysregulation to sarcomagenesis
Sarcomas are cancers of mesenchymal origin. Though they comprise 15-20% of childhood cancers, and have a 5-year survival rate of 16% for metastatic disease, few targeted therapies exist, and the underlying mechanisms of their development are poorly understood. Transcriptional coactivators TAZ and YA...
Main Author: | Hall, Sarah Lynne |
---|---|
Other Authors: | Tanas, Munir |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2017
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/5769 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=7259&context=etd |
Similar Items
-
Snail1 Expression Is Required for Sarcomagenesis
by: Lorena Alba-Castellón, et al.
Published: (2014-05-01) -
Clinical and biological implications of Hippo pathway dysregulation in sarcomas
by: Kyriazoglou Anastasios, et al.
Published: (2019-07-01) -
The Role of Hiwi in Stem Cell Maintenance and Sarcomagenesis
by: Siddiqi, Sara
Published: (2012) -
Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling
by: Zhiguo Chen, et al.
Published: (2020-10-01) -
Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis
by: Manuel Pedro Jimenez-García, et al.
Published: (2021-08-01)